Subsequent mechanistic investigation showed that PI3K targeting in HPV(+) HNSCC cells could result in a feedback upregulation of ERBB3 signaling via E6 and E7 induction, thus conferring PI3K resistance. Here, PIK3CB is linked to head and neck squamous cell carcinoma.